ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

• In a meaningful effort to improve childhood cancer outcomes in low- and middle-income countries (LMICs), Childhood Cancer International (CCI), IDA Foundation, the International Society of Paediatric Oncology (SIOP), Resonance, Servier, and World Child Cancer have joined forces to launch the Access Cancer Treatment (ACT) for Children. This unique collaboration, working closely with the Union for International Cancer Control (UICC)-led Access to Oncology Medicines (ATOM) Coalition, combines access to innovative, curative childhood cancer medicines with high-quality clinical care and patient support, laying the foundation for long-term, sustainable impact.
• In just six months, the initiative has implemented key care improvement strategies and delivered $2.3 million worth of high-quality, innovative pediatric oncology medicines to childhood cancer centers in Asia and Central America, helping to reduce financial barriers and ensure access to children in LMICs.
• OncoDaily—one of the largest online platforms for oncology news—has pledged to keep the global community informed about the initiative and drive greater awareness of the huge inequities in pediatric cancer care.

 OncoDaily, February 12, 2025 – Today, a select group of organizations, including OncoDaily, announced a collaborative initiative, Access Cancer Treatment (ACT) for Children. The initiative is aligned with the WHO CureAll framework to address disparities in pediatric cancer care in LMICs. This partnership seeks to transform the landscape of childhood cancer care in LMICs by ensuring that children receive quality medical care and support, including life-saving medications essential to the treatment of pediatric acute lymphoblastic leukemia (ALL), the most common type of childhood cancer (1).

“We are honored to be part of this wonderful initiative. The mission of OncoDaily is to be the voice of oncology globally, a place, where everyone around the world has a space, and addressing inequalities in cancer, especially in pediatric cancer field, is one of our major focuses,”said Prof. Gevorg Tamamyan, Editor-in-chief of OncoDaily and President of SIOP Asia and POEM Group. “Kids with cancer can not fight it alone, and we must unite all our efforts for that mission”.

 ACT for Children has already achieved these milestones:

• With the help of the UICC-led ATOM Coalition, IDA Foundation, CCI and local patient organizations, Servier has provided $2.3 million worth of high-quality, essential medicines at no cost to childhood cancer centers in Asia and Central America.
• IDA Foundation ensured the safe delivery of these medicines by leveraging its 50 years of supply chain expertise, managing logistics, and supporting import processes for smooth distribution.
• Resonance, a global contract research organization (CRO) specializing in pediatric oncology, is sponsoring and implementing registries and quality improvement initiatives, including providing data management systems to monitor and track improvements in child cancer outcomes.
• SIOP and World Child Cancer launched specialized hands-on education and patient support programs aimed at improving diagnosis and treatment outcomes, and empowering families.
• World Child Cancer launched a global awareness and fundraising campaign, #CancelChildCancer.
• CCI and its members provide essential support and care services—such as accommodation, nutrition, psychosocial counselling, and transport—to ensure that patients and their families are able to access and adhere to treatment. CCI also advocates globally for awareness and better resources, policies, and practices for the betterment of childhood cancer treatment and care.
• With the help of Resonance, Servier is strengthening local healthcare capacity by employing data managers, patient navigators, and other essential care providers.

Every year, thousands of children in LMICs experience cancer alongside significant inequalities that impact their chances of survival. Counterfeit and substandard medicines, insufficient medical education, and lack of access to proper diagnostics and multi-disciplinary treatment are among the factors driving alarmingly low survival rates—which can be as low as 30%, compared to approximately 80% in most high-income countries (2). Each partner—suppliers, logistics partners, healthcare professionals and more—plays a key role in ensuring sustainable access to care, which would not be possible through individual efforts.

There are plans to expand these initiatives to additional childhood cancer centers in the coming year to build momentum for long-term, sustainable improvements in treating childhood cancer on a global scale.

Looking ahead, the partners will:

• Advocate for stricter regulation of counterfeit and substandard medicines, ensuring secure supply chains.
• Leverage IDA Foundation’s expertise and advanced tools to ensure sustainable and efficient access to innovative treatments.
• Expand education programs for healthcare providers in alignment with WHO-endorsed best practices.
• Scale up data management systems to enhance clinical care across multiple regions.
• In collaboration, CCI and World Child Cancer will advance family support programs. A special focus for CCI will be developing nutrition programs in focus countries where such nutritional support programs need development or are lacking.
• Drive awareness and action to ensure equitable access to life-saving cancer treatments for all children.

As part of their commitment to advancing pediatric cancer care, OncoDaily and SIOP will host the Second Global OncoThon, a 24-hour virtual event on February 15, 2025, in honor of International Childhood Cancer Day. Bringing together global leaders, celebrities, healthcare professionals, innovators, and advocates, the OncoThon aims to raise critical funds for pediatric cancer research and tackle disparities in treatment access, particularly in LMICs. Save the date and join us for this pivotal day of solidarity and progress.

Press Contact: [email protected].

About OncoDaily: OncoDaily is a global leader in oncology media, delivering timely news and updates from the field of cancer research, treatment, and advocacy. Guided by the motto “Cancer doesn’t take a day off, neither do we,” OncoDaily remains at the forefront of global oncology communication.